| What is RSS feed? | About Us |
 |
 Search Score: 5/10
Source: www.sfgate.com --- 17 days ago
Fluidigm Corp. is ending its effort to go public because turbulence in the financial markets made it impossible to complete the offering, the company said Thursday. The small South San Francisco company, which makes biomedical research tools, had struggled to... ... Source: www.nzherald.co.nz --- 10 days ago
New Zealand biotechnology company Zygem will be introducing the world to new technology to speed up DNA testing, it announced yesterday. Zygem was set up by technology investment company WaikatoLink in 2005 to commercialise DNA... ... Source: www.moreover.com --- 19 days ago
Philadelphia Inquirer Sep 24 2008 5:52PM GMT ... Source: www.moreover.com --- 42 days ago
Biz Journals Sep 1 2008 4:21AM GMT ...
Source: www.press-citizen.com --- 33 days ago
The University of Iowa is suing one of the largest biotechnology companies in the world for allegedly infringing on their patents. ... Source: www.labcanada.com --- 5 days ago
Montreal, QC - Caprion Proteomics says it has been awarded a $12.9 million contract by the National Institute of Al... [ Full Story ] ... Source: www.vindy.com --- 1 day ago
The Firm is meeting with government and private scientists. ... Source: www.bignewsnetwork.com --- 32 days ago
Department of Defense phase one grant comes through the federal Small Business Technology Transfer (STTR) program, part of the small business innovative research program (SBIR). Grants are made to com... ... Source: www.fwicki.com --- 22 days ago
The small South San Francisco company, which makes biomedical research tools, postponed its IPO from today to late Monday, when it hopes to become one of only seven venture-backed companies to go public this ... ... Source: www.vccircle.com --- 38 days ago
Private equity backed Biotech company Avestha Gengraine Technologies Pvt Ltd (Avesthagen) has appointed DSP Merrill Lynch as its lead manager and four other banks - Deutsche Bank, Morgan Stanley, UBS and ICICI Securities - as advisors to its upcoming public offering. The Bangalore-based Firm will file the draft red herring prospectus (DRHP) soon and is not going for any pre-IPO placement, according to a report. According to earlier reports the Firm was planning to raise $100 million through its IPO. read more ... Source: www.beloblog.com --- 38 days ago
The Montel Williams MS Foundation today announced a grant to Providence-based Epivax, Inc., the first Biotech-related company to be awarded a grant from the foundation. Epivax is a privately held company run by Anne Searls DeGroot that is dedicated to... ... Source: www.tobaccojournal.com --- 9 days ago
Philip Morris International has purchased a large percentage of shares in Medicago, a Canadian Firm, which plans to make vaccines from tobacco leaves. ... Source: coburn.senate.gov --- 14 days ago
... Source: news.yahoo.com --- 5 days ago
AP - WHAT HAPPENED: Indianapolis-based drug maker Eli Lilly & Co. is buying the Biotech Firm ImClone Systems Inc. for more than $6 billion. ...
Source: blog.washingtonpost.com --- 10 days ago
Vital Signs is our new blog-in-a-blog on the Washington area's Biotech and health care scene. By Kendra Marr After more than a decade in business, HealthExtras decided that it was time to change its name. No, there isn't a merger. This isn't some attempt to cover up a scandal. And the Rockville Firm certainly isn't departing from its core business of managing pharmacy benefits. It's just that the company has outgrown its original brand. This...Please click on the title to continue reading this entry. ... Source: blog.washingtonpost.com --- 2 days ago
Vital Signs is our blog-in-a-blog on the Washington area's Biotech and health care scene. By Kendra Marr Ever wonder who sorts through all the data that powers your all-knowing health insurance company? Samuel A. McKinney did. McKinney was surprised to find a concerned letter from Blue Cross Blue Shield in his mailbox wondering why he had stopped taking his medication: Immediately consult a physician about your medication if it's too expensive or causing side effects, the insurer advised. Trouble was, he had just filled the prescription. So, he called and discovered that Resolution Health, a Columbia-based health analytics Firm, was helping insurers keep closer tabs their members. Armed with a massive databases -- medical and pharmacy claims, lab reports, provider reports and other statistics -- Resolution analyzes personal health information. More than 1,000 computer algorithms dissect the data for millions of members, scanning for ways to cut costs, eliminate conflicting ... Source: www.forbes.com --- 20 days ago
Carl Ichan's Biotech Firm thinks Bristol-Myers' $5.4B hostile bid isn't enough. ... Source: www.forbes.com --- 13 days ago
German Merck indicates it might join Bristol-Myers in a bid for the Biotech Firm. ... Find more results for Biotech Firm on RSSMicro.com |
Related Content |
Copyright © 2008 RSSMicro.com
AFP - US pharmaceutical company Eli Lilly said Monday it had agreed a takeover worth 6.5 billion dollars with Biotech Firm ImClone, which is also a target for rival Bristol-Myers Squibb (BMS). ...